Texas Movement Disorder Specialists, PLLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Parkinson disease3 trials

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Cerevance1 trial
• Cerevance Beta, Inc.1 trial
• Impax Laboratories, LLC1 trial

Running trials

• Recruiting

  A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  NCT06765668· Phase 4· Impax Laboratories, LLC· Source

  Contact: Michael Soileau

• Active, not recruiting

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· Phase 3· Cerevance· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease1 recruiting

Closed trials

• Completed

  Early Parkinson's Disease Monotherapy With CVN424

  NCT06006247· Phase 2· Cerevance Beta, Inc.· Source